PL371295A1 - Hfa-suspension formulation of an anhydrate - Google Patents
Hfa-suspension formulation of an anhydrateInfo
- Publication number
- PL371295A1 PL371295A1 PL03371295A PL37129503A PL371295A1 PL 371295 A1 PL371295 A1 PL 371295A1 PL 03371295 A PL03371295 A PL 03371295A PL 37129503 A PL37129503 A PL 37129503A PL 371295 A1 PL371295 A1 PL 371295A1
- Authority
- PL
- Poland
- Prior art keywords
- hfa
- anhydrate
- suspension formulation
- formulation
- suspension
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10214264A DE10214264A1 (en) | 2002-03-28 | 2002-03-28 | HFA suspension formulations of an anhydrate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL371295A1 true PL371295A1 (en) | 2005-06-13 |
Family
ID=28050990
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL03371295A PL371295A1 (en) | 2002-03-28 | 2003-03-20 | Hfa-suspension formulation of an anhydrate |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1492498A2 (en) |
| JP (1) | JP5147158B2 (en) |
| KR (1) | KR101005717B1 (en) |
| CN (1) | CN1642525A (en) |
| AU (1) | AU2003221509B2 (en) |
| BR (1) | BR0308709A (en) |
| CA (1) | CA2479638C (en) |
| DE (1) | DE10214264A1 (en) |
| EA (1) | EA008610B1 (en) |
| EC (1) | ECSP045322A (en) |
| HR (1) | HRP20040890A2 (en) |
| IL (1) | IL163696A0 (en) |
| ME (1) | ME00246B (en) |
| MX (1) | MXPA04009338A (en) |
| NO (1) | NO20044004L (en) |
| NZ (1) | NZ536030A (en) |
| PL (1) | PL371295A1 (en) |
| RS (1) | RS52481B (en) |
| UA (1) | UA79776C2 (en) |
| WO (1) | WO2003082244A2 (en) |
| ZA (1) | ZA200405637B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2606549A1 (en) * | 2005-05-02 | 2006-11-09 | Boehringer Ingelheim International Gmbh | Crystalline forms of tiotropium bromide |
| KR20080007656A (en) * | 2005-05-02 | 2008-01-22 | 베링거 인겔하임 인터내셔날 게엠베하 | Novel crystalline forms of tiotropium bromide |
| CA2763941A1 (en) * | 2009-05-29 | 2010-12-02 | Pearl Therapeutics, Inc. | Compositions, methods & systems for respiratory delivery of two or more active agents |
| AU2015201037C1 (en) * | 2009-05-29 | 2017-07-27 | Pearl Therapeutics, Inc. | Respiratory delivery of active agents |
| US8815258B2 (en) | 2009-05-29 | 2014-08-26 | Pearl Therapeutics, Inc. | Compositions, methods and systems for respiratory delivery of two or more active agents |
| BR112015022784B1 (en) | 2013-03-15 | 2023-02-14 | Pearl Therapeutics, Inc | MICRONIZED CRYSTALLINE MATERIAL CONDITIONING METHOD AND CONDITIONING SYSTEMS |
| EP3515439B1 (en) * | 2016-09-19 | 2021-12-15 | Mexichem Fluor S.A. de C.V. | Pharmaceutical composition comprising tiotropium bromide |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3931041C2 (en) * | 1989-09-16 | 2000-04-06 | Boehringer Ingelheim Kg | Esters of thienyl carboxylic acids with amino alcohols, their quaternization products, processes for their preparation and medicaments containing them |
| CN1150890C (en) * | 1998-08-04 | 2004-05-26 | 杰格研究股份公司 | Medicinal aerosol formulations |
| GB0009605D0 (en) * | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Medicaments |
| GB0009606D0 (en) * | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Therapeutic combinations |
| GB0009592D0 (en) * | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Respiratory combinations |
| GB0009583D0 (en) * | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Respiratory formulations |
| DE10111058A1 (en) * | 2001-03-08 | 2002-09-12 | Boehringer Ingelheim Pharma | New drug compositions based on anticholinergics and NK¶1¶ receptor antagonists |
| CA2436537C (en) * | 2000-10-31 | 2009-05-26 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions comprising tiotropium salts and antihistamines |
| DE10113366A1 (en) * | 2001-03-20 | 2002-09-26 | Boehringer Ingelheim Pharma | Medicament for treating inflammatory or obstructive respiratory diseases, e.g. asthma or chronic obstructive pulmonary disease, containing synergistic combination of anticholinergic agent and endothelin antagonist |
-
2002
- 2002-03-28 DE DE10214264A patent/DE10214264A1/en not_active Withdrawn
-
2003
- 2003-03-20 ME MEP-2008-473A patent/ME00246B/en unknown
- 2003-03-20 KR KR1020047015174A patent/KR101005717B1/en active IP Right Grant
- 2003-03-20 CN CNA038072475A patent/CN1642525A/en active Pending
- 2003-03-20 UA UA20041008758A patent/UA79776C2/en unknown
- 2003-03-20 RS YU86004A patent/RS52481B/en unknown
- 2003-03-20 EA EA200401159A patent/EA008610B1/en unknown
- 2003-03-20 IL IL16369603A patent/IL163696A0/en unknown
- 2003-03-20 NZ NZ536030A patent/NZ536030A/en not_active IP Right Cessation
- 2003-03-20 BR BR0308709-3A patent/BR0308709A/en active Pending
- 2003-03-20 MX MXPA04009338A patent/MXPA04009338A/en active IP Right Grant
- 2003-03-20 AU AU2003221509A patent/AU2003221509B2/en not_active Expired
- 2003-03-20 WO PCT/EP2003/002899 patent/WO2003082244A2/en active Application Filing
- 2003-03-20 CA CA2479638A patent/CA2479638C/en not_active Expired - Fee Related
- 2003-03-20 JP JP2003579782A patent/JP5147158B2/en not_active Expired - Lifetime
- 2003-03-20 EP EP03717219A patent/EP1492498A2/en not_active Withdrawn
- 2003-03-20 PL PL03371295A patent/PL371295A1/en not_active Application Discontinuation
-
2004
- 2004-07-15 ZA ZA2004/05637A patent/ZA200405637B/en unknown
- 2004-09-23 NO NO20044004A patent/NO20044004L/en not_active Application Discontinuation
- 2004-09-27 HR HR20040890A patent/HRP20040890A2/en not_active Application Discontinuation
- 2004-09-28 EC EC2004005322A patent/ECSP045322A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL163696A0 (en) | 2005-12-18 |
| AU2003221509A1 (en) | 2003-10-13 |
| BR0308709A (en) | 2005-01-04 |
| MXPA04009338A (en) | 2005-01-25 |
| NO20044004L (en) | 2004-10-05 |
| UA79776C2 (en) | 2007-07-25 |
| EP1492498A2 (en) | 2005-01-05 |
| NZ536030A (en) | 2006-07-28 |
| KR20040098022A (en) | 2004-11-18 |
| AU2003221509B2 (en) | 2008-01-24 |
| JP2005527550A (en) | 2005-09-15 |
| WO2003082244A2 (en) | 2003-10-09 |
| CA2479638C (en) | 2011-01-04 |
| EA008610B1 (en) | 2007-06-29 |
| MEP47308A (en) | 2011-02-10 |
| KR101005717B1 (en) | 2011-01-05 |
| JP5147158B2 (en) | 2013-02-20 |
| RS52481B (en) | 2013-02-28 |
| EA200401159A1 (en) | 2005-04-28 |
| ZA200405637B (en) | 2005-07-27 |
| YU86004A (en) | 2006-08-17 |
| DE10214264A1 (en) | 2003-10-16 |
| CN1642525A (en) | 2005-07-20 |
| WO2003082244A3 (en) | 2004-02-05 |
| CA2479638A1 (en) | 2003-10-09 |
| HRP20040890A2 (en) | 2005-06-30 |
| ECSP045322A (en) | 2005-01-28 |
| ME00246B (en) | 2011-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU154703S (en) | Set of trocars | |
| EG23458A (en) | Set of elements for assemlying structures | |
| ITMI20021228A1 (en) | COMPOSITIONS OF CROSS-LINKABLE POLYURETHANE | |
| AU2003301451A1 (en) | Component capable of being cooled | |
| IL166331A0 (en) | 5-arylterazole compounds compositions thereof and uses therefor | |
| GB0207438D0 (en) | Formulation | |
| EP1577280A4 (en) | Method of deuterization | |
| AU2003226487A8 (en) | Formulation | |
| AU2003279841A1 (en) | Uses of human zven antagonists | |
| AU2003302372A8 (en) | Formulations of finasteride | |
| PL372655A1 (en) | Compositions of pentafluoropropane | |
| IL163696A0 (en) | Hfa-suspension formulation of an anhydrate | |
| GB2388064B (en) | Precise positioning of an object | |
| PL371427A1 (en) | New uses of substituted aminoalkanephosphonic acids | |
| AU2003216848A1 (en) | Deracemisation of amines | |
| AU2003298725A8 (en) | Preparation of metallotexaphyrins | |
| AU2003267800A1 (en) | Methods of using ccr1 antagonists as immunomodulatory agents | |
| PL356853A1 (en) | Application of bacteriphages | |
| IL165356A0 (en) | Preparation of 4-haloalkylkylnicotinamides | |
| GB0222015D0 (en) | Means of assembly-bozz 2 | |
| SI1537210T1 (en) | Decoy-oligonucleotide-inhbition of cd40-expression | |
| EP1511485A4 (en) | Novel uses of dl-thp | |
| SI1509241T1 (en) | Novel uses of cephaibols | |
| HUP0203929D0 (en) | New use of substituted alkyl-piridazinone derivatives | |
| GB0225040D0 (en) | Formulation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |